Addressing the Critical Gap: Conscious Sedation for Pediatric Oncology Patients in LMICs
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
Most newly diagnosed pediatric cancer patients reside in LMICs. These countries face challenges in providing quality treatment, particularly with procedures requiring stillness or causing pain. Conscious sedation (CS) is underutilized in LMICs due, causing treatment delays and adverse outcomes. Advocacy for CS teams, training, and policy support is essential to improve outcomes.
References
1.
Majeed A, Wright T, Guo B, Arora R, Lam C, Martiniuk A
. The Global Impact of COVID-19 on Childhood Cancer Outcomes and Care Delivery - A Systematic Review. Front Oncol. 2022; 12:869752.
PMC: 9023072.
DOI: 10.3389/fonc.2022.869752.
View
2.
. The global burden of childhood and adolescent cancer in 2017: an analysis of the Global Burden of Disease Study 2017. Lancet Oncol. 2019; 20(9):1211-1225.
PMC: 6722045.
DOI: 10.1016/S1470-2045(19)30339-0.
View
3.
Hanna T, King W, Thibodeau S, Jalink M, Paulin G, Harvey-Jones E
. Mortality due to cancer treatment delay: systematic review and meta-analysis. BMJ. 2020; 371:m4087.
PMC: 7610021.
DOI: 10.1136/bmj.m4087.
View
4.
Koh J, Palermo T
. Conscious sedation: reality or myth?. Pediatr Rev. 2007; 28(7):243-8.
DOI: 10.1542/pir.28-7-243.
View
5.
Leelataweedwud P, Vann Jr W
. Adverse events and outcomes of conscious sedation for pediatric patients: study of an oral sedation regimen. J Am Dent Assoc. 2002; 132(11):1531-9; quiz 1596.
DOI: 10.14219/jada.archive.2001.0086.
View